Navigation Links
InterMune in Medical News

Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations

SAN FRANCISCO, March 18 /PRNewswire-USNewswire/ -- W. Scott Harkonen, M.D., the former CEO of InterMune Inc., was indicted on wire fraud and felony Food, Drug and Cosmetic Act charges for his role in the creation and dissemination of false and misleading information about the efficacy of Inter...

New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report

...d Tripep Release Additional Interim Results for ChronVac-C(R) II-56 intermune Starts Clinical Study of ITMN-191 II-57 Roche and Associates Commence C... and Ortho-Clinical II-66 Peregrine Opens Subsidiary in China II-66 intermune Completes Production Milestone II-66 Arrow Expands Hepatitis C Pipeline...

Important Data Presented on Independent Predictors of Mortality in Patients With Idiopathic Pulmonary Fibrosis

...uch an index." About the CAPACITY Program intermune has reported the results of two concurrent, random...ported in the du Bois presentation at ATS. intermune expects to submit a new drug application (NDA) to ... rash and gastrointestinal symptoms. About intermune ...

InterMune to Present at Cowen Health Care Conference

...er or download any necessary software. About intermune intermune is a biotechnology company focused on the research...novative therapies in pulmonology and hepatology. intermune has a pipeline portfolio addressing idiopathic pul...

InterMune Reports Results from Triple Combination Study of ITMN-191

...Chairman, Chief Executive Officer and President of intermune said, "We are very pleased to report that in this ...All-oral STAT-C study) In November 2008, Roche, intermune and Pharmasset initiated the first all-oral combin...ar. Conference Call and Webcast Details intermune will host a conference call today at 8:30 a.m. EST...

InterMune to Present at Thomas Weisel Partners Healthcare Conference

...wnload any necessary software. About InterMune intermune is a biotechnology company focused on the research...nnovative therapies in pulmonology and hepatology. intermune has a research and development portfolio addressin...et in hepatology. For additional information about intermune and its R&D pipeline, please visit http://www.int...

InterMune to Present at the 2008 Wachovia Healthcare Conference

...wnload any necessary software. About InterMune intermune is a biotechnology company focused on the research...nnovative therapies in pulmonology and hepatology. intermune has a pipeline portfolio addressing idiopathic pul...et in hepatology. For additional information about intermune and its R&D pipeline, please visit http://www.int...

Manufacturer to Pay $20 Million for Improperly Promoting a Sleep Disorder Drug

...l scrutiny recently for their drug marketing practices. In October, intermune of Brisbane agreed to pay $36.9 million to settle federal charges it engage...ting a bone disorder and a condition that makes people prone to infections, intermune was accused of improperly promoting it to treat a fatal lung disease. ...
InterMune in Medical Technology

Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C

PRINCETON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ), Roche (SWX: ROG) and InterMune, Inc. (Nasdaq: ITMN ) today announced that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV)....

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

...enerally well tolerated in both CAPACITY studies. intermune is preparing a New Drug Application (NDA) expected...To better understand the primary efficacy outcome, intermune conducted an exploratory analysis that interrogate...for the treatment of IPF. Webcast Details intermune will host a teleconference and webcast, with accom...

Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen

...loped by other companies. The collaborations with intermune and Pharmasset position Roche as a leader in devel... for HCV. Dial-In and Webcast Details intermune and Pharmasset will host a live webcast of a discu...INFORM-1 trial. Members of management from Roche, intermune and Pharmasset will also be available to answer qu...

Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C

...els of HCV(<15 IU/ml) after 4 weeks, compared to 60 percent in the standard of care arm. In November 2008, Roche, Pharmasset and intermune initiated the INFORM-1 trial to investigate the combination of R7128 with InterMune's R7227, a protease inhibitor, in HCV patients. This is the first-...

InterMune Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver (EASL)

...file of ITMN-191 observed will be confirmed." intermune noted that a Phase 2b triple combination trial of ... INFORM-1 Program In November 2008, Roche, intermune and Pharmasset initiated the first all-oral combin...meeting on Saturday, April 25, 2009. About intermune ...

InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3

...IPF) prior to market open on Tuesday, February 3. intermune will conduct a conference call and webcast, with a...ntering the conference ID# 84164912. About intermune intermune is a biotechnology company focused on the research...

InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191

...ntering the conference ID# 80676348. About intermune intermune is a biotechnology company focused on the research...et in hepatology. For additional information about intermune and its R&D pipeline, please visit htpp:// www...

InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009

...ng with a total daily dose of 300mg. About intermune intermune is a biotechnology company focused on the research...s in hepatology. For additional information about intermune and its R&D pipeline, please visit http://www...

InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C

...ic hepatitis C virus (HCV) genotype 1 infection. intermune also reported that results from the only cohort of... ITMN-191 when given with Pegasys and ribavirin. intermune expects to announce top-line results from the trip...r of this year. Publication Plans for ITMN-191 intermune intends to submit several abstracts regarding ITMN...

InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA

...ast and Conference Call on May 20, 5:00 p.m. EDT intermune additionally announced that it will conduct a live...wnload any necessary software. About InterMune intermune is a biotechnology company focused on the research...nnovative therapies in pulmonology and hepatology. intermune has a research and development portfolio addressin...
InterMune in Biological Technology

Evotec Expands Collaboration With InterMune

Fragment-Based Drug Discovery Program Yields Results and Leads to Expansion of Collaboration HAMBURG, Germany and OXFORD, England, March 6 /PRNewswire-FirstCall/ -- Evotec AG (Frankfurt Stock Exchange: EVT) today announced that InterMune, Inc., has signed a second drug...

InterMune to Present at Canaccord Adams Conference

... or download any necessary software. About intermune intermune is a biotechnology company focused on the research...novative therapies in pulmonology and hepatology. intermune has an R&D portfolio addressing idiopathic pul...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

...ond quarter and six months ended June 30, 2009. intermune reported a net loss for the second quarter of 2009...eral months have been exceptionally productive for intermune and the coming months promise to be even more so. ...esults for the Three Months Ended June 30, 2009 intermune reported total revenue in the second quarter of 20...

InterMune to Release Second Quarter Financial Results on August 6

...live conference call and webcast will be hosted by intermune at 4:30 p.m. Eastern time that same day. To...ntering the conference ID# 22196018. About intermune intermune is a biotechnology company focused on the research...

InterMune to Present at Goldman Sachs Healthcare Conference

...er or download any necessary software. About intermune intermune is a biotechnology company focused on the research...novative therapies in pulmonology and hepatology. intermune has a pipeline portfolio addressing idiopathic pul...

Results From Phase 3 CAPACITY Program of Pirfenidone in IPF and Study of Predictors of Mortality in IPF to be Presented at ATS

...HE CAPACITY TRIALS) Webcast Details intermune will host a teleconference and webcast on Tuesday,... entering the conference ID# 97738057. About intermune intermune is a biotechnology company focused on the research...

Pharmasset Reports Fiscal Second Quarter 2009 Financial Results

...lion, or $0.57 per share for the quarter ended March 31, 2008. Recent Highlights: On April 25, 2009, Pharmasset, Roche, and intermune reported results from the INFORM-1 trial as an oral late breaker at the European Association for the Study of the Liver (EASL) in Copenhagen, Denmark....

InterMune Reports First Quarter 2009 Financial Results and Business Highlights

...ons for the first quarter ended March 31, 2009. intermune reported a net loss for the first quarter of 2009 ... to sharing those results as they develop." intermune reported total revenue in the first quarter of 200...tions of Actimmune for the treatment of IPF, which intermune does not promote. Research and development ...

INFORM-1 Clinical Trial Amended to Further Explore Promising Direct Antiviral Regimen in HCV Patients

...tract can be viewed at www.easl.ch About intermune intermune is a biotechnology company focused on the research...novative therapies in pulmonology and hepatology. intermune has an R&D portfolio addressing idiopathic pul...

InterMune to Release First Quarter Financial Results on April 30

...live conference call and webcast will be hosted by intermune at 4:30 p.m. Eastern time that same day. To ... entering the conference ID# 95970767. About intermune intermune is a biotechnology company focused on the research...
Other Tags
(Date:7/3/2015)... ... ... will hopefully be getting a large donation of canned food items at the end ... making it their mission to collect as many canned items as possible. Donations do not ... as well. As part of the canned food drive, these local chiropractors will be donating ...
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top ... mesothelioma with even minimal asbestos exposure. Click here to read the complete story ... of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University exposed mice ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie County ... 2015 at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of William ... practical points of investigating these types of cases. , Each year, New York ...
(Date:7/3/2015)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... Director of its Frisco facility. , “We are pleased to announce that Dr. Manzanares ... Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Manzanares received ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... The Celebrity ... or cocktail dresses similar to those of celebrities will have the opportunity to get ... at checkout. This ensures that people do not have to use coupon codes or ...
Breaking Medicine News(10 mins):Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2
(Date:6/16/2015)... GOTHENBURG, Sweden , June 16, 2015 ... including all touch fingerprint sensors in the company,s portfolio from ... . Deliveries are planned to mainly take place during the ... manufacturers in Asia . Jörgen ... another evidence of    the   growing interest from smartphone ...
(Date:6/15/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") a ... announces that its leading payment security technology, the Wocket® smart ... NYC June 18th. Digital Experience! @ NYC is ... to over 300 of the top media covering the sector. ... New York City from 6:00 to ...
(Date:6/9/2015)... MINNETONKA, Minn. , June 9, 2015   ... that supports the entire spectrum of clinical research, will ... eClinical technology platform at the 2015 Drug Information ... on June 15-17.  These presentations will include ... be rolled out in the upcoming iMedNet ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3
Other Contents